This review summarizes the pathophysiology, diagnosis, and management of mitral valve prolapse in patients with Marfan syndrome.
May inform management of mitral valve prolapse in Marfan syndrome; leaves open the need for prospective trials.
Marfan syndrome is a multisystemic genetic condition affecting connective tissue. It carries a reduced life expectancy, largely dependent on cardiovascular complications. More common cardiac manifestations such as aortic dissection and aortic valve incompetence have been widely documented in the literature. Mitral valve prolapse (MVP), however, has remained poorly documented. This article aims at exploring the existing literature on the pathophysiology and diagnosis of MVP in patients with Marfan syndrome, defining its current management and outlining the future developments surrounding it.
No takes yet. Share an insight, caveat, or question.
Amitabh Thacoor (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: